Sort
48,018 grants matching “immunotherapy”
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer
$609,531Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2020 · CA
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer
$609,495Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2021 · CA
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
$609,273Sumithira Vasu · Ohio State University · R01 · FY2023 · CA
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
$609,273Sumithira Vasu · Ohio State University · R01 · FY2025 · CA
Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
$609,156Adam Goode · Duke University · R01 · FY2025 · AR
Molecular Epidemiology of non-Hodgkin Lymphoma Survival
$609,140James R Cerhan · Mayo Clinic Rochester · R01 · FY2009 · CA
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy
$609,073Dan Landau · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
$609,048Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Role of mouse microbiome in cancer and inflammation
$608,998Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Regulation of human dendritic cell activation
$608,998Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
$608,954Traci Leigh Hilton · Ubivac, Llc · R44 · FY2013 · CA
Development of a 3D multi-modal perfusion-thermal electrode system
$608,893Xiaoming Yang · University Of Washington · R01 · FY2022 · EB
Immunological and Microbial Mechanisms in Food Allergy
$608,769Talal Amine Chatila · Boston Children'S Hospital · R01 · FY2025 · AI
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
$608,731Donald Ym Leung · National Jewish Health · U01 · FY2024 · AR
Immune injury as a driver for the development of ascending aortic aneurysms and dissections
$608,729Zhihua Jiang · University Of Florida · R01 · FY2020 · HL
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$608,669Nicholas C Denko · Ohio State University · R01 · FY2024 · CA
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
$608,666Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
$608,661Ahmed Kaseb · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Mechanisms of immune-epithelial crosstalk in tissue repair
$608,645Shruti Naik · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AI
Integrative Targeted Therapy for Melanoma
$608,620Jin-Ming Yang · University Of Kentucky · R01 · FY2025 · CA
Toward translation of a plant virus-based in situ vaccination nanotechnology
$608,501Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2023 · CA
Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC) on Immunotherapy
$608,465Despina Kontos · University Of Pennsylvania · R01 · FY2021 · CA
Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays
$608,411Stephen R. Bowen · University Of Washington · R01 · FY2025 · CA
Immunologic Responses to Cow's Milk Proteins in IgE-mediated Cow's Milk Allergy
$608,398Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2010 · AI
Mechanisms of Translation Control in Humans
$608,321Jamie H Cate · University Of California Berkeley · R35 · FY2024 · GM